CLINICAL_TRIALS
trial_result
· 2026-04-17
Clinical Trial Update: Vamikibart in Participants With Uveitic Macular Edema [Phase 3]
Summary
Phase 3 clinical trial of Vamikibart for uveitic macular edema has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Uveitic Macular Edema | Phase 3 | Status: COMPLETED